{"id":1873,"date":"2017-07-02T22:29:55","date_gmt":"2017-07-02T22:29:55","guid":{"rendered":"https:\/\/sepnwg.ro\/2017\/?page_id=1873"},"modified":"2017-11-12T12:52:13","modified_gmt":"2017-11-12T12:52:13","slug":"program","status":"publish","type":"page","link":"https:\/\/sepnwg.ro\/2017\/program\/","title":{"rendered":"Program"},"content":{"rendered":"<p>[vc_row el_class=&#8221;jx-ievent-padding no-top-padding&#8221;][vc_column]\n\t\t\t\t\t<div class=\"jx-ievent-title-2 jx-ievent-dark\">\n\t\t\t\t\t\t<div class=\"jx-ievent-title jx-ievent-uppercase\"><span> Scientific Program<\/span><\/div>\n\t\t\t\t\t\t<div class=\"jx-ievent-hr-title\"><\/div>\n\t\t\t\t   <\/div>\n\t\t\t\t[vc_column_text]<\/p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"5\" width=\"623\"><strong>Friday, November 17<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr style=\"background-color: #ffffcc;\">\n<td width=\"65\">08:00<\/td>\n<td colspan=\"4\" width=\"558\">Registrations<\/td>\n<\/tr>\n<tr style=\"background-color: #99ccff;\">\n<td width=\"65\">08.50<\/td>\n<td colspan=\"4\" width=\"558\">Welcomme message &#8211; Constantinos Stefanidis, Adrian Lungu<\/td>\n<\/tr>\n<tr style=\"background-color: #c9e4ff;\">\n<td width=\"65\"><\/td>\n<td colspan=\"4\" width=\"558\"><strong>1<sup>st<\/sup> session &#8211; LUPUS<\/strong><\/p>\n<p><strong><em>Chairs: Todor Arsov, Constantinos Stefanidis<\/em><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"65\">09:00<\/td>\n<td colspan=\"2\" width=\"330\">Session introduction + Speakers<\/td>\n<td width=\"160\">Todor Arsov<\/td>\n<td width=\"68\">China<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">09:05<\/td>\n<td colspan=\"2\" width=\"330\">SLE \/ inflammation &#8211; and the kidneys; a perspective from a clinical immunologist<\/td>\n<td width=\"160\">Marija Jelusic<\/td>\n<td width=\"68\">Croatia<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">09:25<\/td>\n<td colspan=\"2\" width=\"330\">LUPUS Nephritis &#8211; the pathologist perspective<\/td>\n<td width=\"160\">Mihaela Gherghiceanu<\/td>\n<td width=\"68\">Romania<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">09:45<\/td>\n<td colspan=\"2\" width=\"330\">SLE and genes &#8211; a perspective of a genomic immunologist<\/td>\n<td width=\"160\">Carola Vinuesa<\/td>\n<td width=\"68\">Australia<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">10:15<\/td>\n<td colspan=\"2\" width=\"330\">Centre for Personalized Immunology (CPI and CACPI) collaboration<\/td>\n<td width=\"160\">Carola Vinuesa<\/td>\n<td width=\"68\">Australia<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">10:35<\/td>\n<td colspan=\"2\" width=\"330\">The &#8220;other&#8221; side of personalized genetics\/genomics<\/td>\n<td width=\"160\">Todor Arsov<\/td>\n<td width=\"68\">China<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">10:55<\/td>\n<td colspan=\"2\" width=\"330\"><em>Discussion<\/em><\/td>\n<td width=\"160\"><\/td>\n<td width=\"68\"><\/td>\n<\/tr>\n<tr style=\"background-color: #ffffcc;\">\n<td colspan=\"5\" width=\"623\"><center><em>Coffee break<\/em><\/center><\/td>\n<\/tr>\n<tr style=\"background-color: #c9e4ff;\">\n<td width=\"65\"><\/td>\n<td colspan=\"4\" width=\"558\"><strong>2<sup>nd<\/sup> session \u2013 Complement and Kidney disease<\/strong><\/p>\n<p><strong>Chairs: <em>Zoltan Prohaszka, Tanja Kersnik Levart<\/em><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"65\">11:30<\/td>\n<td colspan=\"2\" width=\"330\">Romanian outbreak of E Coli O:26 Hemolytic Uremic Syndrome<\/td>\n<td width=\"160\">Mihaela Balgradean<\/td>\n<td width=\"68\">Romania<\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">11:50<\/td>\n<td colspan=\"2\" width=\"330\">Complement in Kidney Disease<\/td>\n<td width=\"160\">Zoltan Prohaszka<\/td>\n<td width=\"68\">Hungary<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">12:10<\/td>\n<td colspan=\"2\" width=\"330\">C3 glomerulopathy<\/td>\n<td width=\"160\">Tanja Kersnik Levart<\/td>\n<td width=\"68\">Slovenia<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">12:30<\/td>\n<td colspan=\"2\" width=\"330\">Eculizumab treatment in aHUS \u2013 Romanian Experience<\/td>\n<td width=\"160\">Adrian Lungu<\/p>\n<p>&nbsp;<\/td>\n<td width=\"68\">Romania<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">12:50<\/td>\n<td colspan=\"2\" width=\"330\"><em>Discussion<\/em><\/td>\n<td width=\"160\"><\/td>\n<td width=\"68\"><\/td>\n<\/tr>\n<tr style=\"background-color: #ffffcc;\">\n<td colspan=\"2\" width=\"391\"><center><em>Lunch break<\/em><\/center><\/td>\n<td colspan=\"3\" width=\"232\"><center><em>POSTERS<\/em><\/center><\/td>\n<\/tr>\n<tr style=\"background-color: #c9e4ff;\">\n<td width=\"65\"><\/td>\n<td colspan=\"4\" width=\"558\"><strong>3<sup>rd<\/sup>session \u2013 CKD, HTA, Renal Transplant<\/strong><\/p>\n<p><strong><em>Chairs: Adrian Covic, Liliana Garneata<\/em><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"65\">14:30<\/td>\n<td colspan=\"2\" width=\"330\">Current Concepts and Management Strategies in Chronic Kidney Disease-Mineral and Bone Disorder<\/p>\n<p>&nbsp;<\/td>\n<td width=\"160\">Adrian Covic<\/p>\n<p>&nbsp;<\/td>\n<td width=\"68\">Romania<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">14:50<\/td>\n<td colspan=\"2\" width=\"330\">Hypoproteic diets seem to delay dialysis in CKD patients. Is it valid for children?<\/td>\n<td width=\"160\">Liliana Garneata<\/td>\n<td width=\"68\">Romania<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">15:10<\/td>\n<td colspan=\"2\" width=\"330\">Challenges in histocompatibility and immunogenetics for kidney transplantation<\/td>\n<td width=\"160\">Ileana Constantinescu<\/td>\n<td width=\"68\">Romania<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">15:30<\/td>\n<td colspan=\"2\" width=\"330\">Vascular Access in Children on Hemodialysis<\/td>\n<td width=\"160\">Constantinos Stefanidis<\/td>\n<td width=\"68\">Greece<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">15:50<\/td>\n<td colspan=\"2\" width=\"330\">Practical point of pediatric hypertension management<\/td>\n<td width=\"160\">Stella Stabouli<\/td>\n<td width=\"68\">Greece<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">16:10<\/td>\n<td colspan=\"2\" width=\"330\"><em>Discussion<\/em><\/td>\n<td width=\"160\"><\/td>\n<td width=\"68\"><\/td>\n<\/tr>\n<tr style=\"background-color: #ffffcc;\">\n<td colspan=\"5\" width=\"623\"><center><em>Coffee break<\/em><\/center><\/td>\n<\/tr>\n<tr style=\"background-color: #c9e4ff;\">\n<td width=\"65\"><\/td>\n<td colspan=\"4\" width=\"558\"><strong>4<sup>th<\/sup> session\u00a0 &#8211; Glomerular disease<\/strong><\/p>\n<p><strong><em>Chairs: Fatih Ozaltin, Francesco Emm<\/em><\/strong><strong><em>a<\/em><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"65\">16:30<\/td>\n<td colspan=\"2\" width=\"330\">Genetics of Nephrotic Syndrome<\/td>\n<td width=\"160\">Fatih Ozaltin<\/td>\n<td width=\"68\">Turkey<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">16:50<\/td>\n<td colspan=\"2\" width=\"330\">Immunology of the Nephrotic syndrome<\/td>\n<td width=\"160\">Francesco Emma<\/td>\n<td width=\"68\">Italy<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">17:10<\/td>\n<td colspan=\"2\" width=\"330\">Henoch-Schonlein Purpura nephritis &#8211; what&#8217;s new?<\/td>\n<td width=\"160\">Brankica Spasojevic<\/td>\n<td width=\"68\">Serbia<\/td>\n<\/tr>\n<tr>\n<td width=\"65\">17:30<\/td>\n<td colspan=\"2\" width=\"330\"><em>Discussion<\/em><\/td>\n<td width=\"160\"><\/td>\n<td width=\"68\"><\/td>\n<\/tr>\n<tr style=\"background-color: #ffffcc;\">\n<td colspan=\"5\" width=\"623\"><center><em>Dinner<\/em><\/center><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/vc_column_text][vc_column_text]<\/p>\n<table>\n<tbody>\n<tr>\n<td colspan=\"4\" width=\"623\"><strong>Saturday, November 18<\/strong><\/p>\n<p>&nbsp;<\/td>\n<\/tr>\n<tr style=\"background-color: #c9e4ff;\">\n<td width=\"64\"><\/td>\n<td colspan=\"3\" width=\"559\"><strong>5th session \u2013 Tubular and metabolic kidney disease<\/strong><\/p>\n<p><strong><em>Chairs: Francesco Emma, Sevcan Bakkaloglu<\/em><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"64\">09:00<\/td>\n<td width=\"315\">The kidney and mitochondrial cytopathies<\/td>\n<td width=\"155\">Francesco Emma<\/td>\n<td width=\"89\">Italy<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">09:20<\/td>\n<td width=\"315\">CriticalCareNephrology &#8211; Biomarkers<\/td>\n<td width=\"155\">Mihai Popescu<\/td>\n<td width=\"89\">Romania<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">09:40<\/td>\n<td width=\"315\">Metabolic Causes for Nephro-lithiasis<\/td>\n<td width=\"155\">Danko Milosevic<\/td>\n<td width=\"89\">Croatia<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">10:00<\/td>\n<td width=\"315\">Primary Hyperoxaluria<\/td>\n<td width=\"155\">Sevcan Bakkaloglu<\/td>\n<td width=\"89\">Turkey<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">10:20<\/td>\n<td width=\"315\">Genetics of Nephrocalcinosis<\/td>\n<td width=\"155\">Velibor Tasic<\/td>\n<td width=\"89\">Macedonia<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">10:40<\/td>\n<td width=\"315\"><em>Discussion<\/em><\/td>\n<td width=\"155\"><\/td>\n<td width=\"89\"><\/td>\n<\/tr>\n<tr style=\"background-color: #ffffcc;\">\n<td colspan=\"4\" width=\"623\"><center><em>Coffee break<\/em><\/center><\/td>\n<\/tr>\n<tr style=\"background-color: #c9e4ff;\">\n<td width=\"64\"><\/td>\n<td colspan=\"3\" width=\"559\"><strong>6<sup>th<\/sup> session\u2013 Tubular and metabolic kidney disease<\/strong><\/p>\n<p><strong><em>Chairs: Katharina Hohenfellner, Elena Levtchenko<\/em><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"64\">11:30<\/td>\n<td width=\"315\">Diagnostics and Genetics in Nephropatic Cystinosis<\/td>\n<td width=\"155\">Katharina Hohenfellner<\/td>\n<td width=\"89\">Germany<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">11:50<\/td>\n<td width=\"315\">Practical experience of Nephropatic Cystinosis in Slovakia<\/td>\n<td width=\"155\">Ludmila Podracka<\/td>\n<td width=\"89\">Slovakia<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">12:10<\/td>\n<td width=\"315\">Genetic and pathophysiology of renal Fanconi syndrome<\/td>\n<td width=\"155\">Elena Levtchenko<\/td>\n<td width=\"89\">Belgium<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">12:30<\/td>\n<td width=\"315\">Bartter and Gitelman syndromes<\/td>\n<td width=\"155\">Varvara Askiti<\/td>\n<td width=\"89\">Greece<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">12:50<\/td>\n<td width=\"315\"><em>The impact of the treatment with L-Methionine for Urolithiasis (Solartium Symposium)<\/em><\/td>\n<td width=\"155\">Adrian Lungu<\/td>\n<td width=\"89\">Romania<\/td>\n<\/tr>\n<tr style=\"background-color: #ffffcc;\">\n<td colspan=\"2\" width=\"379\"><center><em>Lunch break<\/em><\/center><\/td>\n<td colspan=\"2\" width=\"244\"><center><em>\u00a0<\/em><\/center><\/td>\n<\/tr>\n<tr style=\"background-color: #c9e4ff;\">\n<td width=\"64\"><\/td>\n<td colspan=\"3\" width=\"559\"><strong>7<sup>th<\/sup> session \u2013 UTI, CAKUT<\/strong><\/p>\n<p><strong><em>Chairs: Constantinos Stefanidis, Erik Van Hoorde<\/em><\/strong><\/td>\n<\/tr>\n<tr>\n<td width=\"64\">14:30<\/td>\n<td width=\"315\">VUR: from the Nephrologist to the Surgeon. Who gets it first?<\/td>\n<td width=\"155\">Bogdan Dima<\/td>\n<td width=\"89\">Belgium<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">15:10<\/td>\n<td width=\"315\">Renal parenchymal damage in the\u00a0 first febrile urinary tract infection and the TNF, ACE, PAI1 and MTHFR genes<\/td>\n<td width=\"155\">Danka Pokrajac<\/p>\n<p>&nbsp;<\/td>\n<td width=\"89\">Bosnia and Herzegovina<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">15:40<\/td>\n<td width=\"315\">How to prevent the development of renal scars in children with febrile urinary tract infections<\/td>\n<td width=\"155\">Constantinos Stefanidis<\/p>\n<p>&nbsp;<\/td>\n<td width=\"89\">Greece<\/td>\n<\/tr>\n<tr>\n<td width=\"64\">16:00<\/td>\n<td width=\"315\"><em>Discussion<\/em><\/td>\n<td width=\"155\"><\/td>\n<td width=\"89\"><\/td>\n<\/tr>\n<tr style=\"background-color: #ffffcc;\">\n<td colspan=\"4\" width=\"623\"><center><em>Conclusions and closing remarks<\/em><\/center><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>[\/vc_column_text][\/vc_column][\/vc_row][vc_row][vc_column]\n\t\t\t\t<div class=\"jx-ievent-section-title-1 jx-ievent-dark\">\n\t\t\t\t\t<div class=\"jx-ievent-pre-title jx-ievent-short-border\">\n\t\t\t\t\t<div class=\"jx-ievent-title-border left\"><\/div>\n\t\t\t\t\t<div class=\"jx-ievent-title-icon\"><i class=\"line-icon vc_li vc_li-news\"><\/i><\/div>\n\t\t\t\t\t<div class=\"jx-ievent-title-border right\"><\/div> \n\t\t\t\t\t<\/div>\n\t\t\t\t\t<div class=\"jx-ievent-title jx-ievent-uppercase\">ACCEPTED ABSTRACTS:<\/div>\n\t\t\t\t\t<div class=\"jx-ievent-subtitle\"><p><\/p><\/div>\n\t\t\t\t\t<!-- Section Title -->\n\t\t\t\t<\/div>\n\t\t\t[\/vc_column][\/vc_row][vc_row][vc_column][vc_column_text]<strong>P 01. <\/strong><strong>ROMANIAN OUTBREAK OF E.COLI O:26 HEMOLYTIC UREMIC SYNDROME<\/strong><\/p>\n<p>Authors : Mihaela Balgradean,\u00a0 Anca Croitoru<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 02. <\/strong><strong>MYH9-RELATED DISEASE AS A MULTIDISCIPLINARY PROBLEM<\/strong><\/p>\n<p>Authors: Aksenova Marina, Suntsova Elena, Kalinina Anna, Arseneva Anna, Playsunova Svetlana, Raikina Tatiana, Machan Michail, Novichkova Galina<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>P 03. <\/strong><strong>ASPERGILLUS PERITONITIS IN PERITONEAL DIALYSIS PATIENTS: A CRITICAL REVIEW<\/strong><\/p>\n<p>Authors: Koukloumperi Eirini, Dotis John, PrintzaNikoleta, Stabouli Stella, KaravaVasiliki, GkogkaChrysa, PapachristouFotios<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>P 04. <\/strong><strong>WHAT MIGHT BE THE DIAGNOSIS IN A PATIENT WITH SEIZURES, DEVELOPMENTAL DELAY, METABOLIC ALKALOSIS AND HYPOKALEMIA?<\/strong><\/p>\n<p>Authors: Evangelia Gole, Varvara Askiti, Argyroula Zampetoglou, Constantinos J. Stefanidis<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>P 05. <\/strong><strong>NO RELATIONSHIP BETWEEN GLUTATHIONE-S-TRANSFERASE T1 AND M1 AND NEPHROTIC SYNDROME IN A ROMANIAN POPULATION<\/strong><\/p>\n<p>Authors: Carmen Duicu, Florin Tripon, AlinaBoglis, Andrei Crauciuc, Cornel Aldea, Dan Delean, Claudia Banescu<\/p>\n<p><strong>\u00a0<\/strong><\/p>\n<p><strong>P 06. <\/strong><strong>NO ASSOCIATION BETWEEN GLUTATHIONE PEROXIDASE 1 GENE POLYMORPHISM AND YOUNG NEPHROTIC SINDROME PATIENTS<\/strong><\/p>\n<p>Authors: Tripon Florin, Crauciuc George Andrei, Aldea Cornel, B\u0103nescu Claudia, Duicu Carmen<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 07. <\/strong><strong>DIAGNOSTIC CHALLENGES OF CONGENITAL ANOMALIES OF THE GENITOURINARY TRACT <\/strong><\/p>\n<p>Authors: Teofana Bizerea, Ramona Stroescu, Otilia Marginean, Vlad David, Simona Cerbu, Adrian Craciun, Gafencu Mihai<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 08. <\/strong><strong>DIAGNOSIS AND EVOLUTION OF A ROMANIAN GIRL WITH CYSTINOSIS<\/strong><\/p>\n<p>Authors: Cecilia Lazea, Alexandra Popa, Rodica Manasia, Lucia Sur, Carmen Asavoaie, Marianne Grueneberg, Barbara Kutryb-Zajac<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 09. <\/strong><strong>PREDICTED INDIRECTLY RECOGNIZABLE HLA EPITOPES CLASS II SCORE IN PEDIATRIC KIDNEY TRANSPLANTATION \u2013 EXPERIENCE OF A SINGLE CENTER <\/strong><\/p>\n<p>Authors: AndreeaLiana R\u00e3chi\u015fan, Valerie Dubois,Bruno Ranchin, Anne-Laure Leclerc Sellier,AureliaBertholet Thomas, Pierre Cochat, Justine Bacchetta<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 10. <\/strong><strong>AUTOSOMAL DOMINANT MULTICYSTIC DYSPLASTIC KIDNEY PHENOTYPE \u2013 NO GENOTYPE IDENTIFIED (YET)<\/strong><\/p>\n<p>Authors: Jurca-Simina Iulia-Elena, Chirita-Emandi Adela, Nicoleta Andreescu, Olariu Nicu, Isac Raluca, Jurca-Simina Florin-Ioan, Gafencu Mihai, Puiu Maria<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 11. <\/strong><strong>NEPHROGENIC DIABETES INSIPIDUS \u2013AFFECTING THREE MALES IN TWO GENERATIONS<\/strong><\/p>\n<p>Authors: Ramona Stroescu, Mihai Gafencu, Adela Chiri\u0163\u0103, RalucaIsac, FlaviaFarkas,Gabriela Doro\u015f<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 12. <\/strong><strong>TREATMENT FOR INDUCTION OF REMISSION IN LUPUS, WHAT TO CHOOSE?<\/strong><\/p>\n<p>Authors: Adrian Lungu,Andrei Capitanescu, Camelia Pantoc, Cristina Stoica<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 13. <\/strong><strong>HEPATIC MANIFESTATIONS AT THE ONSET OF SYSTEMIC LUPUS ERYTHEMATOSUS: CASE REPORT<\/strong><\/p>\n<p>Authors: Anca-Elena Marin, Adrian Lungu, Diana Baducu, Iulia Constantinescu, Ileana Negru, Camelia Pantoc, Andrei Capitanescu, Cristina Stoica<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 14. <\/strong><strong>ROMANIAN CHILDREN KIDNEY REGISTRY &#8211; NATIONAL DATA REPORT<\/strong><\/p>\n<p>Authors: Iulia Constantinescu, Adrian Lungu, Anca Marin, Alexandra Niculae, Andrei Capitanescu, Ileana Negru, Raluca Slabu, Cristina Stoica<\/p>\n<p>&nbsp;<\/p>\n<p><strong>P 15. COMPLEMENT FACTOR H MUTATION ATYPICAL HEMOLYTIC UREMIC SYNDROME \u2013 10 MONTHS ON DIALYSIS WITH PARTIAL RECOVERY OF THE RENAL FUNCTION AFTER ECULIZUMAB THERAPY \u2013 CASE REPORT<\/strong><\/p>\n<p>Authors: Alexandra Niculae, Adrian Lungu, DorinaTacu, Andrei Capitanescu, Cristina Stoica, Zoltan Prohaszka[\/vc_column_text][\/vc_column][\/vc_row]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>[vc_row el_class=&#8221;jx-ievent-padding no-top-padding&#8221;][vc_column][vc_column_text] Friday, November 17 &nbsp; 08:00 Registrations 08.50 Welcomme message &#8211; Constantinos Stefanidis, Adrian Lungu 1st session &#8211; LUPUS Chairs: Todor Arsov, Constantinos Stefanidis 09:00 Session introduction + Speakers Todor Arsov China 09:05 SLE \/ inflammation &#8211; and the kidneys; a perspective from a clinical immunologist Marija Jelusic Croatia 09:25 LUPUS Nephritis &#8211; [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"footnotes":""},"_links":{"self":[{"href":"https:\/\/sepnwg.ro\/2017\/wp-json\/wp\/v2\/pages\/1873"}],"collection":[{"href":"https:\/\/sepnwg.ro\/2017\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/sepnwg.ro\/2017\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/sepnwg.ro\/2017\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/sepnwg.ro\/2017\/wp-json\/wp\/v2\/comments?post=1873"}],"version-history":[{"count":38,"href":"https:\/\/sepnwg.ro\/2017\/wp-json\/wp\/v2\/pages\/1873\/revisions"}],"predecessor-version":[{"id":2529,"href":"https:\/\/sepnwg.ro\/2017\/wp-json\/wp\/v2\/pages\/1873\/revisions\/2529"}],"wp:attachment":[{"href":"https:\/\/sepnwg.ro\/2017\/wp-json\/wp\/v2\/media?parent=1873"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}